University of Liege | Version française
Study programmes 2011-2012Last update : 14/06/2012
PHIN2029-2  Regulation and the medical-social environment
- Aspects économiques du développement du médicament
- Legislation and procedures applied to pharmaceutical industry, part a : legislation
- Legislation and procedures applied to pharmaceutical industry, part b : patents and protection
- Environnment macro-économique et pharmaco-économie
- CTD File (Common Technical Document)
- Regulations of preclinical and clinical studies, part a : pharmaceutical toxicological files
- Regulations of preclinical and clinical studies, part b : clinical studies
- Regulations of preclinical and clinical studies, part c : pediatric studies
- Specific regulatory issues, part a : medicine and herbal dietary supplement
- Aspects réglementaires particuliers, partim b : Préformulation et documentation du développement galénique

Duration :  Aspects économiques du développement du médicament : 10h Th
Legislation and procedures applied to pharmaceutical industry, part a : legislation : 10h Th, 5h Pr
Legislation and procedures applied to pharmaceutical industry, part b : patents and protection : 5h Th
Environnment macro-économique et pharmaco-économie : 10h Th
CTD File (Common Technical Document) : 15h Th
Regulations of preclinical and clinical studies, part a : pharmaceutical toxicological files : 15h Th
Regulations of preclinical and clinical studies, part b : clinical studies : 5h Th
Regulations of preclinical and clinical studies, part c : pediatric studies : 2,5h Th
Specific regulatory issues, part a : medicine and herbal dietary supplement : 5h Th
Aspects réglementaires particuliers, partim b : Préformulation et documentation du développement galénique : 5h Th
Number of credits :  
Advanced Master in Industrial PharmacyToute l'année8
Lecturer :  Aspects économiques du développement du médicament : Dominique Martin
Legislation and procedures applied to pharmaceutical industry, part a : legislation : Catherine Druez
Legislation and procedures applied to pharmaceutical industry, part b : patents and protection : Patrick Di Stefano
Environnment macro-économique et pharmaco-économie : Alain De Wever
CTD File (Common Technical Document) : Jean‑Antoine De Muylder
Regulations of preclinical and clinical studies, part a : pharmaceutical toxicological files : Sonia Beken
Regulations of preclinical and clinical studies, part b : clinical studies : Lenaers
Regulations of preclinical and clinical studies, part c : pediatric studies : Daniel Brasseur
Specific regulatory issues, part a : medicine and herbal dietary supplement : Monique Tits
Aspects réglementaires particuliers, partim b : Préformulation et documentation du développement galénique : Francis Verbist
Coordinator :  Philippe Hubert
Language(s) of instruction :  
French language


imageHome
imageSearch by Faculty
imageSearch by teacher
imageSearch by course code and title

Students and Studies Administration - Academic Affairs - Contact : Monique Marcourt, General Director for Education and Training - Developed by SEGI